emodin and dicumarol
emodin has been researched along with dicumarol in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, YY; Hu, QS; Jing, YW; Li, H; Shi, GY; Tang, XM; Yi, J | 1 |
Other Studies
2 other study(ies) available for emodin and dicumarol
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Dicoumarol alters cellular redox state and inhibits nuclear factor kappa B to enhance arsenic trioxide-induced apoptosis.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Dicumarol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Emodin; Enzyme Inhibitors; HeLa Cells; Humans; NF-kappa B; Oxidation-Reduction; Oxides; Reactive Oxygen Species | 2004 |